Published in J Vasc Surg on December 26, 2007
Evaluation of Cilostazol in Combination With L-Carnitine (ECLECTIC) | NCT00822172
Peripheral artery disease: current insight into the disease and its diagnosis and management. Mayo Clin Proc (2010) 1.58
Practice-based evidence: profiling the safety of cilostazol by text-mining of clinical notes. PLoS One (2013) 1.27
A pooled analysis of the durability and predictors of treatment response of cilostazol in patients with intermittent claudication. Vasc Med (2010) 0.99
Cilostazol is associated with improved outcomes after peripheral endovascular interventions. J Vasc Surg (2014) 0.82
Current endovascular therapy for lower extremity peripheral arterial disease: indications, outcomes and modalities. Heart Asia (2009) 0.75
Protocol for Cilostazol Stroke Prevention Study for Antiplatelet Combination (CSPS.com): a randomized, open-label, parallel-group trial. Int J Stroke (2014) 0.75
Trends in antimicrobial drug development: implications for the future. Clin Infect Dis (2004) 5.23
The Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) study: a randomized, double-blinded, placebo-controlled trial. J Antimicrob Chemother (2011) 3.04
The minimally invasive management of visceral artery aneurysms and pseudoaneurysms. J Vasc Surg (2011) 2.06
Endograft migration one to four years after endovascular abdominal aortic aneurysm repair with the AneuRx device: a cautionary note. J Vasc Surg (2002) 1.57
Synthetic peptides that exert antimicrobial activities in whole blood and blood-derived matrices. Antimicrob Agents Chemother (2002) 1.57
Exercise capacity as a predictor of survival among ambulatory patients with end-stage renal disease. Kidney Int (2004) 1.41
The new anticoagulants. Perspect Vasc Surg Endovasc Ther (2007) 1.40
Influence of endograft oversizing on device migration, endoleak, aneurysm shrinkage, and aortic neck dilation: results from the Zenith Multicenter Trial. J Vasc Surg (2004) 1.18
Cardiovascular risks with azithromycin. N Engl J Med (2013) 1.17
Impaired muscle oxygen use at onset of exercise in peripheral arterial disease. J Vasc Surg (2004) 1.16
Risk factors for mortality in patients with mucormycosis. Med Mycol (2012) 1.13
Aortic neck angulation predicts adverse outcome with endovascular abdominal aortic aneurysm repair. J Vasc Surg (2002) 1.11
Position paper: recommended design features of future clinical trials of antibacterial agents for community-acquired pneumonia. Clin Infect Dis (2008) 1.11
Contemporary management of aberrant right subclavian arteries. Ann Vasc Surg (2011) 1.10
Skeletal muscle StO2 kinetics are slowed during low work rate calf exercise in peripheral arterial disease. Eur J Appl Physiol (2007) 1.04
Embracing the fistula first national vascular access improvement initiative. J Vasc Surg (2005) 1.03
Trends in aortic aneurysm surgical training for general and vascular surgery residents in the era of endovascular abdominal aortic aneurysm repair. J Vasc Surg (2002) 0.93
Pulmonary VO2 dynamics during treadmill and arm exercise in peripheral arterial disease. J Appl Physiol (1985) (2004) 0.91
Stroke prevention by cilostazol in patients with atherothrombosis: meta-analysis of placebo-controlled randomized trials. J Stroke Cerebrovasc Dis (2009) 0.91
Clinical and demographic predictors of exercise capacity in end-stage renal disease. Am J Kidney Dis (2002) 0.90
A decision-analysis tool for benefit-risk assessment of nonprescription drugs. J Clin Pharmacol (2013) 0.90
Brachial versus basilic vein dialysis fistulas: a comparison of maturation and patency rates. J Vasc Surg (2008) 0.89
Adjunctive parenteral therapy with lipo-ecraprost, a prostaglandin E1 analog, in patients with critical limb ischemia undergoing distal revascularization does not improve 6-month outcomes. J Vasc Surg (2007) 0.89
Comparison of open and endovascular repair of inflammatory aortic aneurysms. J Vasc Surg (2012) 0.89
Long-term postplacement cost after endovascular aneurysm repair. J Vasc Surg (2007) 0.86
Design of clinical trials of antibacterial agents for community-acquired bacterial pneumonia. Clin Investig (Lond) (2011) 0.84
Impact of a computerized physician order-entry system. J Am Coll Surg (2009) 0.84
Secondary procedures after endovascular aortic aneurysm repair. J Vasc Surg (2002) 0.83
Effect of propionyl-L-carnitine on a background of monitored exercise in patients with claudication secondary to peripheral artery disease. J Cardiopulm Rehabil Prev (2011) 0.83
Potential biomarkers of muscle injury after eccentric exercise. Biomarkers (2010) 0.83
Laparoscopic inferior mesenteric artery ligation: an alternative for the treatment of type II endoleaks. J Laparoendosc Adv Surg Tech A (2003) 0.81
Mid- and long-term device migration after endovascular abdominal aortic aneurysm repair: a comparison of AneuRx and Zenith endografts. J Vasc Surg (2005) 0.80
Late problems at the proximal aortic neck: migration and dilation. Semin Vasc Surg (2004) 0.80
Surgical management of tumors invading the aorta and major arterial structures. Ann Vasc Surg (2011) 0.80
Carnitine replacement in end-stage renal disease and hemodialysis. Ann N Y Acad Sci (2004) 0.79
Current management of peripheral arterial occlusive disease: a review of pharmacologic agents and other interventions. Am J Cardiovasc Drugs (2007) 0.79
Turf wars and silos--the effect of disruptive technologic innovation in the treatment of cerebral and peripheral vascular disease. Catheter Cardiovasc Interv (2007) 0.79
American and German students' knowledge, perceptions, and behaviors with respect to over-the-counter pain relievers. Health Psychol (2007) 0.79
Reimbursement of long-term postplacement costs after endovascular abdominal aortic aneurysm repair. J Vasc Surg (2008) 0.79
Acute bilateral iliac artery occlusion secondary to blunt trauma: successful endovascular treatment. J Vasc Surg (2003) 0.78
The influence of need for cognition and principal display panel factors on over-the-counter drug facts label comprehension. Health Commun (2011) 0.78
A randomized prospective multicenter trial of a novel vascular sealant. Ann Vasc Surg (2012) 0.78
Type 3 phosphodiesterase inhibitors may be protective against cerebrovascular events in patients with claudication. J Stroke Cerebrovasc Dis (2008) 0.78
Does ASA classification impact success rates of endovascular aneurysm repairs? Ann Vasc Surg (2002) 0.78
A comparative analysis of the outcomes of aortic cuffs and converters for endovascular graft migration. J Vasc Surg (2010) 0.78
The Food and Drug Administration and the Future of Drug Development for the Treatment of Diabetes. Diabetes Spectr (2014) 0.78
Iliac artery stent infection treated with superficial femoral vein. J Vasc Surg (2005) 0.77
Antiplatelet medications: old and emerging therapies. Ann Vasc Surg (2009) 0.77
The effect of gender on early and intermediate results of endovascular aneurysm repair. Ann Vasc Surg (2003) 0.77
Patient and hospital-level characteristics associated with the use of do-not-resuscitate orders in patients hospitalized for sepsis. J Gen Intern Med (2014) 0.77
Endovascular repair of an iliac artery aneurysm in a patient with Ehlers-Danlos syndrome type IV. J Vasc Surg (2007) 0.77
A decade of decline: an analysis of Medicare reimbursement for vascular surgical procedures. Ann Vasc Surg (2002) 0.77
The new heparins. Ochsner J (2002) 0.76
Aortic aneurysm sac shrinkage after endovascular repair is device-dependent: a comparison of Zenith and AneuRx endografts. Ann Vasc Surg (2003) 0.76
Explantation of an infected aortic endograft with suprarenal barb fixation. J Vasc Surg (2003) 0.76
From bad behaviour to bad biology: pitfalls and promises in the management of resistant hypertension. Can J Cardiol (2013) 0.76
Commentary. Coronary artery revascularization before elective major vascular surgery. Perspect Vasc Surg Endovasc Ther (2005) 0.76
Should the guidelines for management of central venous catheters in patients with candidemia be changed now? Clin Infect Dis (2010) 0.76
Influence of preoperative risk factors on outcome after carotid endarterectomy. Ochsner J (2003) 0.76
Elimination of pneumothorax and hemothorax during placement of implantable venous access ports using ultrasound and fluoroscopic guidance. Vascular (2013) 0.76
Application of adaptive design and decision making to a phase II trial of a phosphodiesterase inhibitor for the treatment of intermittent claudication. Trials (2011) 0.76
Response to McDermott. Circulation (2014) 0.75
Mid-term results of patients undergoing endovascular aortic aneurysm repair. Am J Surg (2002) 0.75
Premature termination of clinical trials. JAMA (2003) 0.75
Can claudication be improved with medication? Semin Vasc Surg (2002) 0.75
Endovascular exclusion of saccular AAAs using "stacked" AneuRx aortic cuffs. J Endovasc Ther (2002) 0.75
Commentary. Idraparinux versus standard therapy for venous thromboembolic disease. Extended prophylaxis of venous thromboembolism with idraparinux. Perspect Vasc Surg Endovasc Ther (2008) 0.75
Medical management of intermittent claudication. Vasc Endovascular Surg (2004) 0.75
The novel anticoagulants: the surgeons' prospective. Surgery (2012) 0.75
Commentary on: Redgrave JNE, Lovett JK, Gallagher PJ, et al. Histological assessment of 526 symptomatic carotid plaques in relation to the nature and timing of ischemic symptoms: the Oxford Plaque Study. Circulation. 2006; 113:2320-2328. Perspect Vasc Surg Endovasc Ther (2007) 0.75
Spiral vein graft for internal jugular bypass in a patient with multiple sclerosis and suspected chronic cerebrospinal venous insufficiency. Ann Vasc Surg (2013) 0.75
Percutaneous thrombolysis of acute-on-chronic inferior vena cava thrombosis after previous insertion of an Adams-DeWeese clip. Vasc Endovascular Surg (2014) 0.75
Dialysis access flow phenomenon demonstrated via an internal jugular central venous catheter uniquely positioned within a superior vena cava stenosis. Anesthesiology (2012) 0.75
Successful percutaneous management of ruptured middle colic aneurysm following endovascular aneurysm repair. Vasc Endovascular Surg (2014) 0.75
Endo-exuberance to endo-reality: trends in the management of 431 AAA repairs between 1996 and 2002. J Endovasc Ther (2003) 0.75
Endovascular retrieval of a TrapEase permanent inferior vena cava filter from the aorta. J Vasc Surg (2011) 0.75
Importance of access to fixed-imaging fluoroscopy: practice implications for the vascular surgeon. J Endovasc Ther (2004) 0.75
The thoracic endograft: a minimally invasive treatment option for aortic diseases. J La State Med Soc (2008) 0.75
Safety of carotid endarterectomy in patients concurrently on clopidogrel. Ann Vasc Surg (2009) 0.75
Ruptured hepatic artery aneurysm: a novel approach to distal control. J Vasc Surg (2007) 0.75
Midterm outcomes of the Zenith Renu AAA Ancillary Graft. J Vasc Surg (2011) 0.75
Long-term postplacement cost comparison of AneuRx and Zenith endografts. Ann Vasc Surg (2008) 0.75
Differential management of cardiovascular disease in ESRD by nephrologists and cardiologists. Am J Kidney Dis (2004) 0.75